Systematic review of the association between lung function and Type 2 diabetes mellitus

Diabetic Medicine

Volumn 27, Issue 9, 2010, Pages 977-987

  Klein, O L ^a   Krishnan, J A ^b,c   Glick, S ^b   Smith, L J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

diabetes; inflammation; lung function; microangiopathy

Indexed keywords

ADULT; AUTONOMIC NEUROPATHY; CHRONIC INFLAMMATION; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GLUCOSE BLOOD LEVEL; HUMAN; HYPOXIA; INSULIN RESISTANCE; LONGITUDINAL STUDY; LOW BIRTH WEIGHT; LUNG COMPLIANCE; LUNG DIFFUSION CAPACITY; LUNG DISEASE; LUNG FUNCTION; LUNG PARENCHYMA; LUNG VOLUME; MEDLINE; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; REVIEW; SMOKING; SYSTEMATIC REVIEW;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FORCED EXPIRATORY VOLUME; HUMANS; INSULIN RESISTANCE; LUNG DISEASES; RESPIRATORY FUNCTION TESTS;

EID: 77955873004     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2010.03073.x     Document Type: Review

References (51)

1. Orasanu G, Plutzky J. The pathologic continuum of diabetic vascular disease. J Am Coll Cardiol 2009 53 : S35 42.
2. Aronson D. Hyperglycemia and the pathobiology of diabetic complications. Adv Cardiol 2008 45 : 1 16.
3. Brownlee M, Vlassara H, Cerami A. Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann Int Med 1984 101 : 527 537.
4. Hsia CC, Raskin P. Lung involvement in diabetes. Does it matter? Diabetes Care 2008 31 : 828 829.
5. Sandler M. Is the lung a target organ in diabetes mellitus? Arch Intern Med 1990 150 : 1385 1388.
6. Walter RE, Beiser A, Givelber RJ, O'Connor GT, Gottlieb DJ. Association between glycemic state and lung function: the Framingham Heart Study. Am J Respir Crit Care Med 2003 167 : 911 916.
7. Yeh HC, Punjabi NM, Wang NY, Pankow JS, Duncan BB, Cox CE et al. Cross-sectional and prospective study of lung function in adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care 2008 31 : 741 746.
8. Lange P, Parner J, Schnohr P, Jensen G. Copenhagen City Heart Study: longitudinal analysis of ventilator capacity in diabetic and non-diabetic adults. Eur Respir J 2002 20 : 1406 1412.
9. Litonjua AA, Lazarus R, Sparrow D, Demolles D, Weiss ST. Lung function in type 2 diabetes: the Normative Aging Study. Respir Med 2005 99 : 1583 1590.
10. Davis TME, Knuiman M, Kendall P, Vu H, Davis WA. Reduced pulmonary function and its associations in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Res Clin Pract 2000 50 : 153 159.
11. Lawlor DA, Ebrahim S, Smith GD. Associations of measures of lung function with insulin resistance and type 2 diabetes: findings from the British Women's Heart and Health Study. Diabetologia 2004 47 : 195 203.
12. Chance WW, Rhee C, Yilmaz C, Dane DM, Pruneda ML, Raskin P et al. Diminished alveolar microvascular reserves in type 2 diabetes reflect systemic microangiopathy. Diabetes Care 2008 31 : 1596 1601.
13. Yeh HC, Punjabi NM, Wang NY, Pankow JS, Duncan BB, Brancati FL. Vital capacity as a predictor of incident type 2 diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care 2005 28 : 1472 1479.
14. Ford ES, Mannino DM. Prospective association between lung function and the incidence of diabetes: findings from the National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Diabetes Care 2004 27 : 2966 2970.
15. Engström G, Hedblad B, Nilsson P, Wollmer P, Berglund G, Janzon L. Lung function, insulin resistance and incidence of cardiovascular disease: a longitudinal cohort study. J Intern Med 2003 253 : 574 581.
16. Eriksson KF, Lindgärde F. Poor physical fitness, and impaired early insulin response but late hyperinsulinaemia, as predictors of NIDDM in middle-aged Swedish men. Diabetologia 1996 39 : 573 579.
17. Ofulue AF, Thurlbeck WM. Experimental diabetes and the lung. In vivo connective tissue metabolism. Am Rev Respir Dis 1988 138 : 284 289.
18. Popov D, Hasu M, Costache G, Stern D, Simionescu M. Capillary and aortic endothelia interact in situ with non-enzymatically glycated albumin and develop specific alterations in early experimental diabetes. Acta Diabetol 1997 34 : 285 293.
19. Sugahara K, Ushijima K, Morioka T, Usuku G. Studies of the lung in diabetes mellitus. Ultrastructural studies of the lungs in alloxan-induced diabetic rats. Virchows Arch A Pathol Anat Histol 1981 390 : 313 324.
20. Farina J, Furio V, Fernandez-Acenero MJ, Muzas MA. Nodular fibrosis of the lung in diabetes mellitus. Virchows Arch 1995 427 : 61 63.
21. Kodolova IM, Lysenko LV, Saltykov BB. Changes in the lungs in diabetes mellitus. Arkh Patol 1982 44 : 35 40.
22. Vracko R, Thorning D, Huang TW. Basal lamina of alveolar epithelium and capillaries: quantitative changes with aging and in diabetes mellitus. Am Rev Respir Dis 1979 120 : 973 983.
23. Weynand B, Jonckheere A, Frans A, Rahier J. Diabetes mellitus induces a thickening of the pulmonary basal lamina. Respiration 1999 66 : 14 19.
24. Watanabe K, Senju S, Toyoshima H, Yoshida M. Thickness of the basement membrane of bronchial epithelial cells in lung diseases as determined by transbronchial biopsy. Respir Med 1997 91 : 406 410.
25. Fogarty AW, Jones S, Britton JR, Lewis SA, McKeever TM. Systemic inflammation and decline in lung function in a general population: a prospective study. Thorax 2007 62 : 515 520.
26. Thyagarajan B, Jacobs DR, Apostol GG, Smith LJ, Lewis CE, Williams OD. Plasma fibrinogen and lung function: the CARDIA Study. Int J Epidemiol 2006 35 : 1001 1008.
27. Hancox RJ, Poulton R, Greene JM, Filsell S, McLachlan CR, Rasmussen F et al. Systemic inflammation and lung function in young adults. Thorax 2007 62 : 1064 1068.
28. Ford ES. Body mass index, diabetes, and C-reactive protein among US adults. Diabetes Care 1999 22 : 1971 1977.
29. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. J Am Med Assoc 2001 286 : 327 334.
30. Schmidt MI, Duncan BB, Sharrett AR, Lindberg G, Savage PJ, Offenbacher S et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet 1999 353 : 1649 1652.
31. Williams JG, Morris AI, Hayter RC, Ogilvie CM. Respiratory responses of diabetics to hypoxia, hypercapnea and exercise. Thorax 1984 39 : 529 534.
32. Hamlin CR, Kohn RR, Luschin JH. Apparent accelerated aging of human collagen in diabetes mellitus. Diabetes 1975 24 : 902 904.
33. Cheng N, Cai W, Jiang M. Effect of hypoxia on blood glucose, hormones, and insulin receptor functions in newborn calves. Pediatr Res 1997 41 : 852 856.
34. Raff H, Bruder ED, Jankowski BM. The effect of hypoxia on plasma leptin and insulin in newborn and juvenile rats. Endocrine 1999 11 : 37 39.
35. Barker DJ, Godfrey KM, Fall C, Osmond C, Winter PD, Shaheen SO. Relation of birthweight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease. Br Med J 1991 303 : 671 675.
36. Cook JT, Levy JC, Page RC, Shaw JA, Hattersley AT, Turner RC. Association of low birthweight with beta cell function in the adult first degree relatives of non-insulin dependent diabetic subjects. Br Med J 1993 306 : 302 306.
37. Phillips DI, Barker DJ, Hales CN, Hirst S, Osmond C. Thinness at birth and insulin resistance in adult life. Diabetologia 1994 37 : 150 154. (Pubitemid 24042883)
38. Forsén T, Eriksson J, Tuomilehto J, Reunanen A, Osmond C, Barker D. The fetal and childhood growth of persons who develop type 2 diabetes. Ann Intern Med 2000 133 : 176 182.
39. Hsia CC, Raskin P. Lung function changes related to diabetes mellitus. Diabetes Technol Ther 2007 9 : S73 S82.
40. Barrett-Connor E, Frette C. NIDDM, impaired glucose tolerance, and pulmonary function in older adults. The Rancho Bernardo Study. Diabetes Care 1996 19 : 1441 1444.
41. Centers for Disease Control and Prevention. The Burden of Chronic Diseases and Their Risk Factors. Atlanta, GA : Centers for Disease Control and Prevention, 2004. Available at http://www.cdc.gov/nccdphp/burdenbook2004/index. htm Last accessed 31 January 2010.
42. Ryan JG. Cost and policy implications from the increasing prevalence of obesity and diabetes mellitus. Gend Med 2009 6 : S86 108.
43. Kornum JB, Thomsen RW, Riis A, Lervang HH, Schønheyder HC, Sørensen HT. Diabetes, glycemic control, and risk of hospitalization with pneumonia: a population-based case-control study. Diabetes Care 2008 31 : 1541 1545.
44. Falguera M, Pifarre R, Martin A, Sheikh A, Moreno A. Etiology and outcome of community-acquired pneumonia in patients with diabetes mellitus. Chest 2005 128 : 3233 3239.
45. Akbar DH. Bacterial pneumonia: a comparison between diabetics and non-diabetics. Acta Diabetol 2001 38 : 77 82.
46. Guazzi M, Brambilla R, Pontone G, Agostoni P, Guazzi MD. Effect of non-insulin-dependent diabetes mellitus on pulmonary function and exercise tolerance in chronic congestive heart failure. Am J Cardiol 2002 89 : 191 197.
47. Guazzi M, Brambilla R, De Vita S, Guazzi MD. Diabetes worsens pulmonary diffusion in heart failure, and insulin counteracts this effect. Am J Respir Crit Care Med 2002 166 : 978 982.
48. Cefalu WT, Skyler JS, Kourides IA, Landschulz WH, Balagtas CC, Cheng S et al for the Inhaled Insulin Study Group. Inhaled human insulin treatment in patients with type 2 diabetes mellitus. Ann Intern Med 2001 134 : 203 207.
49. Weiss SR, Cheng SL, Kourides IA, Gelfand RA, Landschulz WH. Inhaled insulin provides improved glycemic control in patients with type 2 diabetes mellitus inadequately controlled with oral agents: a randomized controlled trial. Arch Intern Med 2003 163 : 2277 2282.
50. Laube BL. Treating diabetes with aerosolized insulin. Chest 2001 120 : 99S 106S.
51. Hsia CC, Raskin P. The diabetic lung: relevance of alveolar microangiopathy for the use of inhaled insulin. Am J Med 2005 118 : 205 212.